Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers

PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer